PolyPeptide Successfully Closes Financial Year 2025 With Strong Revenue Growth and Marked Improvement in Profitability

PolyPeptide also delivered a marked improvement in profitability in FY 2025, reaching between 11 - 12% EBITDA margin towards the upper end of guidance and up from 7.5% in 2024.

Phosphoramidite Market Size to Reach USD 2.45 Billion by 2034, Driven by DNA Synthesis and Gene Therapy Research

The global phosphoramidite market size was valued at USD 1.29 billion in 2025 and is predicted to hit around USD 2.45 billion ...
Pharmabiz

Codexis expands reach of the ECO Synthesis Manufacturing Platform through a signed evaluation agreement with Axolabs for oligonucleotide therapeutics

Codexis, Inc., a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Group, an oligonucleotide contract research development and ...
Seeking Alpha

Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

REDWOOD CITY, Calif., Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Group, ...
Hosted on MSN

Observation of a new phase of matter at the boundary between solid and liquid

The melting of materials seems like a simple phenomenon. However, when their thickness is reduced to just a few atoms, established rules waver. In this two-dimensional mode, new states emerge between ...